Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Nutex Health (NUTX) Deferred Taxes (2021 - 2026)

Nutex Health (NUTX) has disclosed Deferred Taxes for 7 consecutive years, with -$932000.0 as the latest value for Q1 2026.

For Q1 2026, Deferred Taxes rose 62.72% year-over-year to -$932000.0; the TTM value through Mar 2026 reached $18.6 million, up 219.99%, while the annual FY2025 figure was $17.1 million, 230.02% up from the prior year.
Deferred Taxes hit -$932000.0 in Q1 2026 for Nutex Health, up from -$5.9 million in the prior quarter.
Across five years, Deferred Taxes topped out at $27.8 million in Q3 2025 and bottomed at -$11.4 million in Q4 2024.
Average Deferred Taxes over 5 years is -$647569.3, with a median of -$932000.0 recorded in 2026.
On a YoY basis, Deferred Taxes climbed as much as 4550.0% in 2025 and fell as far as 2531.58% in 2025.
Nutex Health's Deferred Taxes stood at $1.6 million in 2022, then tumbled by 324.44% to -$3.6 million in 2023, then tumbled by 213.04% to -$11.4 million in 2024, then skyrocketed by 48.5% to -$5.9 million in 2025, then surged by 84.11% to -$932000.0 in 2026.
According to Business Quant data, Deferred Taxes over the past three periods came in at -$932000.0, -$5.9 million, and $27.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.